Ashland Inc. News Headlines

ASH 
$117.93
*  
1.52
1.27%
Get ASH Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading ASH now
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Trian initiates a proxy fight with DuPont
1/23/2015 10:33:00 AM - Market Realist


Clorox Company (CLX) Ex-Dividend Date Scheduled for January 26, 2015
1/23/2015 9:00:04 AM - NASDAQ.com News


Valspar (VAL) Prices Debt Offering Worth $500M - Analyst Blog
1/19/2015 5:35:00 PM - Zacks.com


Valspar (VAL) Prices Debt Offering Worth $500M - Analyst Blog
1/19/2015 5:35:00 AM - Investopedia


Sextant Growth Fund's Top Picks: Delta Air, Ashland and BorgWarner
1/16/2015 6:13:00 PM - TheStreet


Sigma-Aldrich's SAFC Validates Dry Powder Media Unit - Analyst Blog
1/16/2015 2:10:00 PM - Investopedia


Sigma-Aldrich's SAFC Validates Dry Powder Media Unit - Analyst Blog
1/16/2015 2:10:00 PM - Zacks.com


Credit Suisse's Top 5 Chemicals Stocks to Buy in 2015 to Beat the Market
1/6/2015 11:24:00 AM - TheStreet


4 Biotech Stocks that Doubled in 2014 - Analyst Blog
12/26/2014 9:00:00 AM - Zacks.com


February 2015 Options Now Available For Ashland (ASH)
12/22/2014 11:33:45 AM - BNK Invest


Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
12/19/2014 1:00:00 AM - Zacks.com


4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog
12/16/2014 11:26:00 AM - Zacks.com


Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data - Analyst Blog
12/10/2014 3:10:00 PM - Zacks.com


AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) - Analyst Blog
12/10/2014 12:54:35 PM - Zacks.com


Alnylam Reports Positive Initial Phase I Data on ALN-AT3 - Analyst Blog
12/9/2014 5:20:00 PM - Zacks.com


Pharmacyclics Presents Imbruvica Data at the ASH Meeting - Analyst Blog
12/9/2014 5:10:00 PM - Zacks.com


Celgene Up on Positive Revlimid Data Presented at ASH - Analyst Blog
12/9/2014 4:40:00 PM - Zacks.com


Novartis Reports Encouraging Data on Biosimilar of Neupogen - Analyst Blog
12/9/2014 3:15:00 PM - Zacks.com


ImmunoGen Reports Encouraging Data on Cancer Drug - Analyst Blog
12/8/2014 4:30:00 PM - Zacks.com


Seattle Genetics-Takeda's Adcetris Shows Long-Term Effect - Analyst Blog
12/8/2014 3:20:00 PM - Zacks.com


AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH - Analyst Blog
12/8/2014 2:50:00 PM - Zacks.com


'Overdue' Dividend Increases (And Other Streaks At Risk)
12/7/2014 6:01:00 PM - Seeking Alpha


Ashland (ASH) Wraps Up Sale of Elastomers Business - Analyst Blog
12/2/2014 3:50:00 PM - Zacks.com


Here's What I Do When the Market Crashes
12/1/2014 10:03:01 AM - Motley Fool


Dividend Champions For December 2014
11/29/2014 7:40:00 AM - Seeking Alpha